| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 4317955
[patent_doc_number] => 06242666
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-05
[patent_title] => 'Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells'
[patent_app_type] => 1
[patent_app_number] => 9/212531
[patent_app_country] => US
[patent_app_date] => 1998-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17168
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/242/06242666.pdf
[firstpage_image] =>[orig_patent_app_number] => 212531
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/212531 | Animal model for identifying a common stem/progenitor to liver cells and pancreatic cells | Dec 15, 1998 | Issued |
| 09/210010 | ECDYSONE RECEPTOR COMPLEX | Dec 10, 1998 | Abandoned |
| 09/206645 | NOVEL HUMAN LIM PROTEINS | Dec 6, 1998 | Abandoned |
Array
(
[id] => 658817
[patent_doc_number] => 07105647
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-09-12
[patent_title] => 'cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use'
[patent_app_type] => utility
[patent_app_number] => 09/555362
[patent_app_country] => US
[patent_app_date] => 1998-11-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22579
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/105/07105647.pdf
[firstpage_image] =>[orig_patent_app_number] => 09555362
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/555362 | cDNAs and proteins involved in hypoxia, circadian and orphan signal transduction pathways, and methods of use | Nov 26, 1998 | Issued |
Array
(
[id] => 1598757
[patent_doc_number] => 06475481
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2002-11-05
[patent_title] => 'Purging of stem cell products'
[patent_app_type] => B2
[patent_app_number] => 09/193599
[patent_app_country] => US
[patent_app_date] => 1998-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 24
[patent_no_of_words] => 8205
[patent_no_of_claims] => 52
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/475/06475481.pdf
[firstpage_image] =>[orig_patent_app_number] => 09193599
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/193599 | Purging of stem cell products | Nov 16, 1998 | Issued |
| 09/191572 | NUCLEIC ACID TRANSFER VECTOR FOR THE INTRODUCTION OF NUCLEIC ACID INTO THE DNA OF A CELL | Nov 12, 1998 | Abandoned |
| 09/171890 | PLURIPOTENT RABBIT EMBRYONIC STEM (ES) CELL LINES AND THEIR USE IN THE GENERATION OF CHIMERIC RABBITS | Oct 27, 1998 | Abandoned |
Array
(
[id] => 6765213
[patent_doc_number] => 20030099611
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-05-29
[patent_title] => 'MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C-PP2CALPHA - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION'
[patent_app_type] => new
[patent_app_number] => 09/029479
[patent_app_country] => US
[patent_app_date] => 1998-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 18584
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0099/20030099611.pdf
[firstpage_image] =>[orig_patent_app_number] => 09029479
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/029479 | MANIPULATION AND DETECTION OF PROTEIN PHOSPHATASE 2C-PP2CALPHA - EXPRESSION IN TUMOR CELLS FOR CANCER THERAPY, PREVENTION AND DETECTION | Oct 20, 1998 | Abandoned |
| 09/176183 | MAMMALIAN TIMELESS AND METHODS OF USE THEREOF | Oct 20, 1998 | Abandoned |
Array
(
[id] => 4300806
[patent_doc_number] => 06251663
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-06-26
[patent_title] => 'Recombinant eukaryotic plasmids containing allergen-gene and use thereof for the prevention and/or treatment of allergic diseases'
[patent_app_type] => 1
[patent_app_number] => 9/166967
[patent_app_country] => US
[patent_app_date] => 1998-10-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 7198
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/251/06251663.pdf
[firstpage_image] =>[orig_patent_app_number] => 166967
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/166967 | Recombinant eukaryotic plasmids containing allergen-gene and use thereof for the prevention and/or treatment of allergic diseases | Oct 5, 1998 | Issued |
Array
(
[id] => 5889070
[patent_doc_number] => 20020013282
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-01-31
[patent_title] => 'CATIONIC AMPHIPILE COMPOSITIONS FOR INTERACELLUAR DELIVERY OF THERAPEUTIC MOLECULES'
[patent_app_type] => new
[patent_app_number] => 09/166074
[patent_app_country] => US
[patent_app_date] => 1998-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 27665
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0013/20020013282.pdf
[firstpage_image] =>[orig_patent_app_number] => 09166074
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/166074 | CATIONIC AMPHIPILE COMPOSITIONS FOR INTERACELLUAR DELIVERY OF THERAPEUTIC MOLECULES | Oct 4, 1998 | Abandoned |
| 09/155291 | ANTITUMOUR CELLULAR COMPOSITIONS EXPRESSING AT LEAST THREE TRANSGENES | Sep 24, 1998 | Abandoned |
Array
(
[id] => 1137905
[patent_doc_number] => 06780644
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-08-24
[patent_title] => 'Use of beta recombinase in eukaryotic cells, especially for transgenic work'
[patent_app_type] => B1
[patent_app_number] => 09/158272
[patent_app_country] => US
[patent_app_date] => 1998-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5891
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/780/06780644.pdf
[firstpage_image] =>[orig_patent_app_number] => 09158272
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/158272 | Use of beta recombinase in eukaryotic cells, especially for transgenic work | Sep 21, 1998 | Issued |
Array
(
[id] => 6638688
[patent_doc_number] => 20020016975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-02-07
[patent_title] => 'DNA-BASED TRANSPOSON SYSTEM FOR THE INTRODUCTION OF NUCLEIC ACID INTO DNA OF A CELL'
[patent_app_type] => new
[patent_app_number] => 09/142593
[patent_app_country] => US
[patent_app_date] => 1998-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 19193
[patent_no_of_claims] => 101
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0016/20020016975.pdf
[firstpage_image] =>[orig_patent_app_number] => 09142593
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/142593 | DNA-based transposon system for the introduction of nucleic acid into DNA of a cell | Sep 9, 1998 | Issued |
Array
(
[id] => 6749863
[patent_doc_number] => 20030044383
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2003-03-06
[patent_title] => 'TISSUE SPECIFIC ADENOVIRAL VECTORS'
[patent_app_type] => new
[patent_app_number] => 09/151376
[patent_app_country] => US
[patent_app_date] => 1998-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 44
[patent_figures_cnt] => 44
[patent_no_of_words] => 37063
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0044/20030044383.pdf
[firstpage_image] =>[orig_patent_app_number] => 09151376
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/151376 | Tissue specific adenoviral vectors | Sep 9, 1998 | Issued |
Array
(
[id] => 1587381
[patent_doc_number] => 06482388
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-19
[patent_title] => 'Combined body length in the selective breeding of thoroughbred racehorses'
[patent_app_type] => B1
[patent_app_number] => 09/149388
[patent_app_country] => US
[patent_app_date] => 1998-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 2325
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 260
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/482/06482388.pdf
[firstpage_image] =>[orig_patent_app_number] => 09149388
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/149388 | Combined body length in the selective breeding of thoroughbred racehorses | Sep 7, 1998 | Issued |
Array
(
[id] => 4353416
[patent_doc_number] => 06215039
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-04-10
[patent_title] => 'Repopulation of testicular seminiferous tubules with foreign cells, corresponding resultant germ cells, and corresponding resultant animals and progeny'
[patent_app_type] => 1
[patent_app_number] => 9/140553
[patent_app_country] => US
[patent_app_date] => 1998-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 12
[patent_no_of_words] => 1998
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/215/06215039.pdf
[firstpage_image] =>[orig_patent_app_number] => 140553
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/140553 | Repopulation of testicular seminiferous tubules with foreign cells, corresponding resultant germ cells, and corresponding resultant animals and progeny | Aug 25, 1998 | Issued |
| 09/139527 | METHODS AND COMPOSITIONS FOR TUMOR REDUCTION | Aug 24, 1998 | Abandoned |
Array
(
[id] => 1050293
[patent_doc_number] => 06861572
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-03-01
[patent_title] => 'Production of proteins in eggs'
[patent_app_type] => utility
[patent_app_number] => 09/486215
[patent_app_country] => US
[patent_app_date] => 1998-08-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8788
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/861/06861572.pdf
[firstpage_image] =>[orig_patent_app_number] => 09486215
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/486215 | Production of proteins in eggs | Aug 20, 1998 | Issued |
Array
(
[id] => 1220275
[patent_doc_number] => 06703209
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-09
[patent_title] => 'Porcine totipotent cells and method for long-term culture'
[patent_app_type] => B1
[patent_app_number] => 09/133352
[patent_app_country] => US
[patent_app_date] => 1998-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 23
[patent_no_of_words] => 13387
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/703/06703209.pdf
[firstpage_image] =>[orig_patent_app_number] => 09133352
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/133352 | Porcine totipotent cells and method for long-term culture | Aug 12, 1998 | Issued |